Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele Bartoletti

Showing results (31-40 of 209) with videos related to

Pageof 21
Sort By:
HIV Clinical Trials|May 18, 2012
Statin therapy decreases serum levels of high-sensitivity C-reactive protein and tumor necrosis factor-α in HIV-infected patients treated with ritonavir-boosted protease inhibitorsLeonardo Calza, Filippo Trapani, Michele Bartoletti, et al.
Journal of Global Antimicrobial Resistance|March 31, 2019
Clinical experience with dalbavancin for the treatment of deep sternal wound infectionMichele Bartoletti, Elisa Mikus, Renato Pascale, et al.
Cancer Treatment Reviews|November 12, 2018
Post-neoadjuvant strategies in breast cancer: From risk assessment to treatment escalationGiacomo Pelizzari, Lorenzo Gerratana, Debora Basile, et al.
Gynecologic Oncology|October 4, 2021
Histological patterns and intra-tumor heterogeneity as prognostication tools in high grade serous ovarian cancersEros Azzalini, Renzo Barbazza, Giorgio Stanta, et al.
Cancer Treatment Reviews|February 29, 2024
Incorporation of anti-PD1 or anti PD-L1 agents to platinum-based chemotherapy for the primary treatment of advanced or recurrent endometrial cancer. A meta-analysisMichele Bartoletti, Marcella Montico, Domenica Lorusso, et al.
Critical Reviews in Oncology/Hematology|June 16, 2024
Severe infections in patients with chronic lymphocytic leukemia included in trials investigating BTK and BCL2 inhibitorsFrancesca R Mauro, Anna Maria Frustaci, Andrea Visentin, et al.
Journal of Advanced Research|March 23, 2023
Silver nitroprusside as an efficient chemodynamic therapeutic agent and a peroxynitrite nanogenerator for targeted cancer therapiesKanwal Asif, Muhammad Adeel, Md Mahbubur Rahman, et al.
Blood Reviews|February 8, 2024
Prevention and management of infectious complications in patients with chronic lymphocytic leukemia (CLL) treated with BTK and BCL-2 inhibitors, focus on current guidelinesMalgorzata Mikulska, Chiara Oltolini, Emanuela Zappulo, et al.
International Journal of Antimicrobial Agents|October 14, 2023
Tolerability of pulsed high-dose L-AmB as pre-emptive therapy in patients at high risk for intra-abdominal candidiasis: A phase 2 study (LAMBDA study)Matteo Rinaldi, Michele Bartoletti, Cecilia Bonazzetti, et al.
Antibiotics (Basel, Switzerland)|June 2, 2021
Epidemiology of Meropenem/Vaborbactam Resistance in KPC-Producing <i>Klebsiella pneumoniae</i> Causing Bloodstream Infections in Northern Italy, 2018Paolo Gaibani, Donatella Lombardo, Linda Bussini, et al.
Pageof 21

Showing results (31-40 of 209) with videos related to

Sort By:
Pageof 21
HIV Clinical Trials|May 18, 2012
Statin therapy decreases serum levels of high-sensitivity C-reactive protein and tumor necrosis factor-α in HIV-infected patients treated with ritonavir-boosted protease inhibitorsLeonardo Calza, Filippo Trapani, Michele Bartoletti, et al.
Journal of Global Antimicrobial Resistance|March 31, 2019
Clinical experience with dalbavancin for the treatment of deep sternal wound infectionMichele Bartoletti, Elisa Mikus, Renato Pascale, et al.
Cancer Treatment Reviews|November 12, 2018
Post-neoadjuvant strategies in breast cancer: From risk assessment to treatment escalationGiacomo Pelizzari, Lorenzo Gerratana, Debora Basile, et al.
Gynecologic Oncology|October 4, 2021
Histological patterns and intra-tumor heterogeneity as prognostication tools in high grade serous ovarian cancersEros Azzalini, Renzo Barbazza, Giorgio Stanta, et al.
Cancer Treatment Reviews|February 29, 2024
Incorporation of anti-PD1 or anti PD-L1 agents to platinum-based chemotherapy for the primary treatment of advanced or recurrent endometrial cancer. A meta-analysisMichele Bartoletti, Marcella Montico, Domenica Lorusso, et al.
Critical Reviews in Oncology/Hematology|June 16, 2024
Severe infections in patients with chronic lymphocytic leukemia included in trials investigating BTK and BCL2 inhibitorsFrancesca R Mauro, Anna Maria Frustaci, Andrea Visentin, et al.
Journal of Advanced Research|March 23, 2023
Silver nitroprusside as an efficient chemodynamic therapeutic agent and a peroxynitrite nanogenerator for targeted cancer therapiesKanwal Asif, Muhammad Adeel, Md Mahbubur Rahman, et al.
Blood Reviews|February 8, 2024
Prevention and management of infectious complications in patients with chronic lymphocytic leukemia (CLL) treated with BTK and BCL-2 inhibitors, focus on current guidelinesMalgorzata Mikulska, Chiara Oltolini, Emanuela Zappulo, et al.
International Journal of Antimicrobial Agents|October 14, 2023
Tolerability of pulsed high-dose L-AmB as pre-emptive therapy in patients at high risk for intra-abdominal candidiasis: A phase 2 study (LAMBDA study)Matteo Rinaldi, Michele Bartoletti, Cecilia Bonazzetti, et al.
Antibiotics (Basel, Switzerland)|June 2, 2021
Epidemiology of Meropenem/Vaborbactam Resistance in KPC-Producing <i>Klebsiella pneumoniae</i> Causing Bloodstream Infections in Northern Italy, 2018Paolo Gaibani, Donatella Lombardo, Linda Bussini, et al.
Pageof 21